KUMC Researches Make Breast Cancer Diagnoses More Accurate

Breast Cancer Diagnoses pic An experienced psychiatrist, Dr. Christie Mensch treats patients through Wyandot Center in Kansas City, Kansas. Before beginning her career, Dr. Christie Mensch completed her residency at the University of Kansas Medical Center (KUMC), an institution she continues to support.

KUMC is home to cutting-edge research that recently produced a new device for storing and analyzing biopsied breast tissue. The device aims to make breast cancer diagnoses more accurate and could potentially reduce the rate of false positives by as much as 25 percent. Dr. Ossama Tawfik, a professor of pathology at KUMC, created the device in an effort to bridge the gap between pathologists and radiologists, who tend to work independently of each other.

Typically, radiologists take the tissue sample and then send it to pathologists. Transported in a liquid preservative, the specimen sometimes incurs damage during transit, and upon arrival pathologists cannot always ascertain the parts of the tissue that need to be analyzed. The new device ensures that the tissues arrive to pathologists in the same position in which the radiologist’s x-rays were taken.

A medical device start-up called Rad/Path Solutions LLC licensed the patented new technology from KUMC last July and plans to bring it to the market in the near future. As of February of 2017, the device is in the approval process with the Food and Drug Administration.